Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Jul 12.
Published in final edited form as: Int J Cardiol. 2012 May 22;158(2):326–329. doi: 10.1016/j.ijcard.2012.04.140

Trends in prevalence, awareness, treatment, and control of hypertension among Chinese adults 1991–2009

Bo Xi 1,*,#, Yajun Liang 2,#, Kathleen Heather Reilly 3, Qijuan Wang 1, Yuehua Hu 4, Weihong Tang 5,*
PMCID: PMC3374129  NIHMSID: NIHMS375413  PMID: 22626836

Hypertension is the main risk factor for cardiovascular disease (CVD), accounting for nearly 45% of global CVD morbidity and mortality [1]. Based on previous national survey data in China, the prevalence of hypertension in adults has increased from 5% in 1959 to 11.3% in 1991 and 18% in 2002 [24]. Although many studies have suggested that the control of hypertension is an effective strategy to prevent CVD [5], only a small percentage of hypertensive patients achieved the goal of systolic and diastolic blood pressure (SBP/DBP)<140/90 mm Hg. The control rate of hypertension in China was only 3% in 1991 and 5% in 2002[3,4].

Recently, three studies from China have investigated the prevalence, awareness, treatment, and control of hypertension in three urban populations [6], and two rural populations [7,8]. Recent trends in hypertension prevalence and control in China on a national level, however, are still unknown.

The China Health and Nutrition Survey (CHNS) is a large-scale, national and successive cross-sectional survey that was designed to explore how the health and nutritional status of the Chinese population has been affected by social and economic changes [9]. A multistage, random cluster process was used to draw study sample from nine provinces (Liaoning, Heilongjiang, Jiangsu, Shandong, Henan, Hubei, Hunan, Guangxi and Guizhou). Participants aged 18 years and older were included in the analysis. Information on age, gender, region (the urban and rural regions were clarified according to their characteristics of economy and social development using data from the China National Bureau of Statistics and China Ministry of Health Statistics), body mass index (BMI), and BP measurements were collected. A total of 8426, 7905, 8509, 9469, 8847, 8980 and 8503 participants were included in the analyses across the seven study periods (1991, 1993, 1997, 2000, 2004, 2006, 2009). Gender distributions across the seven survey periods were homogeneous (P=0.49).

BP was measured by trained examiners using a mercury sphygmomanometer according to a standard protocol [10]. The three BP values were measured on one visit, and the last two of three readings were averaged as the BP values in this study. Prevalent pre-hypertension was defined as SBP/DBP of 120/80 to 140/90 mm Hg and hypertension was defined as SBP/DBP≥140/90 mm Hg or on antihypertensive medications [10]. The same criteria were used for both diabetic and nondiabetic participants [11]. Awareness of hypertension was determined as self-reported diagnosis of hypertension by a physician or other healthcare professional. Treatment of hypertension was defined as self-report use of antihypertensive medications. Treated participants were considered to have their hypertension controlled if their SBP/DBP was less than 140/90 mm Hg. Trends in BP values and the estimated percentages (prevalence, awareness, treatment, and control of hypertension) from 1991 to 2009 were assessed with a multiple linear regression (continuous outcomes) or logistical regression (dichotomous outcomes) model [12] with the adjustment for gender, age, region, and BMI. Since age distributions in the seven study periods varied, the estimated percentages were age-standardized to the China Census population in 2000. A p value<0.05 was considered statistically significant. The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology [13].

Overall, both mean SBP and DBP values increased significantly across seven study visits (Table 1). Mean SBP values increased by 5.4 mm Hg and mean DBP increased by 4.1 mm Hg. Similar significant trends were observed in all subgroups defined by age, sex and region groups (all p<0.05), except for the group older than 60 years (p>0.05). Notably, mean SBP and DBP values increased more rapidly among subjects aged 40–59 years and among those living in rural regions.

Table 1.

Trends in mean SBP and DBP values (mm Hg) among Chinese Adults: the CHNS 1991–2009

Age, y 1991 1993 1997 2000 2004 2006 2009 ptrenda

N Mean(SE) N Mean(SE) N Mean(SE) N Mean(SE) N Mean(SE) N Mean(SE) N Mean(SE)
SBP
Total 8426 114.7 (0.2) 7905 115.1 (0.2) 8509 117.6 (0.2) 9469 118.0 (0.2) 8847 119.5 (0.2) 8980 118.5 (0.2) 8503 120.1 (0.2) <0.001
Age, y
      18–39 4517 108.7 (0.2) 3953 109.7 (0.2) 3788 112.1 (0.2) 3869 112.4 (0.2) 2841 114.1 (0.2) 2551 113.4 (0.2) 2202 113.8 (0.3) <0.001
      40–59 2657 117.3 (0.4) 2712 117.2 (0.3) 3192 119.7 (0.3) 3796 120.7 (0.3) 3962 122.2 (0.3) 4175 121.4 (0.3) 3868 124.1 (0.3) <0.001
      ≥60 1252 132.1 (0.7) 1240 131.0 (0.7) 1529 133.4 (0.6) 1804 133.6 (0.5) 2044 134.1 (0.5) 2254 131.9 (0.4) 2433 135.4 (0.4) 0.421
Sexes
    Men 3987 116.8 (0.3) 3742 117.1 (0.3) 4111 119.4 (0.3) 4508 120.0 (0.2) 4195 121.7 (0.3) 4218 121.0 (0.3) 4007 122.3 (0.3) <0.001
    Women 4439 112.8 (0.3) 4163 113.3 (0.3) 4398 115.7 (0.3) 4961 116.0 (0.3) 4652 117.3 (0.3) 4762 116.3 (0.3) 4496 118.0 (0.3) <0.001
Regions
    Urban 2817 115.4 (0.4) 2422 115.7 (0.4) 2880 116.9 (0.3) 3209 117.4 (0.3) 3070 119.2 (0.3) 3041 118.3 (0.3) 2743 118.9 (0.3) 0.028
    Rural 5609 114.2 (0.2) 5483 114.7 (0.2) 5629 117.7 (0.2) 6260 118.2 (0.2) 5777 119.4 (0.2) 5939 118.6 (0.2) 5760 120.5 (0.3) <0.001
DBP
Total 8426 74.3 (0.1) 7905 75.4 (0.1) 8509 76.5 (0.1) 9469 76.9 (0.1) 8847 77.7 (0.1) 8980 77.6 (0.1) 8503 78.4 (0.1) <0.001
Age, y
      18–39 4517 71.4 (0.1) 3953 72.8 (0.1) 3788 74.0 (0.1) 3869 74.4 (0.2) 2841 75.6 (0.2) 2551 75.4 (0.2) 2202 75.6 (0.2) <0.001
      40–59 2657 76.5 (0.2) 2712 77.4 (0.2) 3192 78.2 (0.2) 3796 79.1 (0.2) 3962 79.8 (0.2) 4175 79.8 (0.2) 3868 81.4 (0.2) <0.001
      ≥60 1252 80.6 (0.4) 1240 81.2 (0.4) 1529 82.4 (0.3) 1804 81.9 (0.3) 2044 81.2 (0.3) 2254 81.4 (0.3) 2433 82.2 (0.2) 0.121
Sexes
    Men 3987 75.8 (0.2) 3742 76.9 (0.2) 4111 77.9 (0.2) 4508 78.5 (0.2) 4195 79.4 (0.2) 4218 79.5 (0.2) 4007 80.4 (0.2) <0.001
    Women 4439 72.9 (0.2) 4163 74.0 (0.2) 4398 75.1 (0.2) 4961 75.4 (0.2) 4652 76.1 (0.2) 4762 75.8 (0.2) 4496 76.4 (0.2) <0.001
Regions
    Urban 2817 74.7 (0.2) 2422 76.2 (0.2) 2880 76.7 (0.2) 3209 76.9 (0.2) 3070 77.7 (0.2) 3041 77.7 (0.2) 2743 78.4 (0.2) <0.001
    Rural 5609 74.0 (0.1) 5483 75.0 (0.1) 5629 76.4 (0.1) 6260 76.9 (0.1) 5777 77.7 (0.2) 5939 77.5 (0.1) 5760 78.4 (0.2) <0.001

The mean SBP and DBP values were age-standardized to the China 2000 Census population

a

Time trends in mean SBP and DBP from 1991 to 2009 were assessed by multiple linear regression analysis with gender, age, region, and BMI adjustment.

The prevalence of pre-hypertension and hypertension changed significantly from 29.4% and 14.5%, respectively, in 1991, to 38.7% and 21.4%, respectively, in 2009 (both p<0.001), with an absolute increase of 9.3% and 6.9% (Table 2). Similar significant trends were observed in each subgroup defined by age, sex or region (all p<0.05). The prevalence of hypertension increased more rapidly among subjects who were older than 40 years, men, and those who lived in rural regions (Table 2).

Table 2.

Trends in prevalence of pre-hypertension and hypertension among Chinese Adults: the CHNS 1991–2009

Age, y 1991 1993 1997 2000 2004 2006 2009 ptrenda

N %(SE) N %(SE) N %(SE) N %(SE) N %(SE) N %(SE) N %(SE)
Pre-hypertension
Total 8426 29.4 (0.5) 7905 33.2 (0.5) 8509 36.6 (0.5) 9469 38.2 (0.5) 8847 40.6 (0.5) 8980 41.0 (0.5) 8503 38.7 (0.5) <0.001
Age, y
      18–39 4517 26.8 (0.7) 3953 31.2 (0.7) 3788 36.2 (0.8) 3869 37.3 (0.8) 2841 41.7 (0.9) 2551 41.4 (1.0) 2202 37.8 (1.0) <0.001
      40–59 2657 33.6 (0.9) 2712 37.4 (0.9) 3192 39.0 (0.9) 3796 41.5 (0.8) 3962 42.6 (0.8) 4175 43.7 (0.8) 3868 42.8 (0.8) <0.001
      ≥60 1252 30.3 (1.3) 1240 32.4 (1.3) 1529 33.0 (1.2) 1804 34.1 (1.1) 2044 32.0 (1.0) 2254 33.8 (1.0) 2433 33.5 (1.0) <0.001
Sexes
    Men 3987 34.2 (0.8) 3742 39.1 (0.8) 4111 41.2 (0.8) 4508 44.5 (0.7) 4195 47.1 (0.8) 4218 47.8 (0.8) 4007 44.4 (0.8) <0.001
    Women 4439 25.2 (0.7) 4163 28.1 (0.7) 4398 32.3 (0.7) 4961 32.3 (0.7) 4652 34.6 (0.7) 4762 34.9 (0.7) 4496 33.5 (0.7) <0.001
Regions
    Urban 2817 29.3 (0.9) 2422 33.6 (1.0) 2880 35.6 (0.9) 3209 38.5 (0.9) 3070 39.0 (0.9) 3041 41.0 (0.9) 2743 38.3 (0.9) <0.001
    Rural 5609 29.6 (0.6) 5483 33.2 (0.6) 5629 37.1 (0.6) 6260 38.1 (0.6) 5777 41.4 (0.6) 5939 41.0 (0.6) 5760 38.9 (0.6) <0.001
Hypertension
Total 8426 14.5 (0.4) 7905 15.5(0.4) 8509 17.9(0.4) 9469 18.2(0.4) 8847 19.1(0.4) 8980 17.8(0.4) 8503 21.4(0.4) <0.001
Age, y
      18–39 4517 4.6 (0.3) 3953 6.0 (0.4) 3788 7.2 (0.4) 3869 7.4 (0.4) 2841 8.2 (0.5) 2551 7.2 (0.5) 2202 8.6 (0.6) <0.001
      40–59 2657 18.2 (0.7) 2712 18.8 (0.7) 3192 21.9 (0.7) 3796 23.0 (0.7) 3962 24.4 (0.7) 4175 23.3 (0.7) 3868 29.3 (0.7) <0.001
      ≥60 1252 43.9 (1.4) 1240 44.8 (1.4) 1529 49.4 (1.3) 1804 48.4 (1.2) 2044 49.0 (1.1) 2254 46.4 (1.1) 2433 53.0 (1.0) 0.014
Sexes
    Men 3987 16.0 (0.6) 3742 16.9 (0.6) 4111 20.0 (0.6) 4508 20.3 (0.6) 4195 21.7 (0.6) 4218 20.4 (0.6) 4007 24.5 (0.7) <0.001
    Women 4439 13.1 (0.5) 4163 14.3 (0.5) 4398 15.8 (0.5) 4961 16.2 (0.5) 4652 16.8 (0.5) 4762 15.5 (0.5) 4496 18.7 (0.6) <0.001
Regions
    Urban 2817 16.4 (0.7) 2422 17.8 (0.8) 2880 18.0 (0.7) 3209 18.6 (0.7) 3070 19.7 (0.7) 3041 17.7 (0.7) 2743 20.5 (0.8) 0.019
    Rural 5609 13.2 (0.5) 5483 14.3 (0.5) 5629 17.5 (0.5) 6260 17.7 (0.5) 5777 18.5 (0.5) 5939 17.7 (0.5) 5760 21.6 (0.5) <0.001

Prevalent pre-hypertension was defined as SBP/DBP of 120/80 to 140/90 mm Hg and hypertension was defined as SBP/DBP≥140/90 mm Hg or on antihypertensive medications

Prevalence were age-standardized to the China 2000 Census population

a

Time trends in pre-hypertension and hypertension from 1991 to 2009 were assessed by multiple logistical regression analysis with gender, age, region, and BMI adjustment.

The awareness and treatment of hypertension decreased significantly from 22.4% and 12.0% respectively, in 1991, to 13.0% and 9.6%, respectively, in 1997 (all p<0.05). However, there was no clear trend in the BP control rates among hypertensive patients and among those treated over time (both p>0.05) (Table 3). During the periods of 1997–2009, the awareness, treatment, and control of hypertension in all hypertensive patients and those treated increased significantly from 13.0%, 9.6%, 1.7% and 17.4% in 1997, respectively, to 26.1%, 22.8%, 6.1%, and 33.1% in 2009 (all p<0.05). In stratified analysis, during the periods of 1997–2009, the rates of awareness, treatment, and control of hypertension in all hypertensive patients and in those treated increased more rapidly in those aged 60 years or older. In addition, the rates of hypertension control in all hypertensive patients and in those treated increased more rapidly in urban regions (Table 3).

Table 3.

Trends in awareness, treatment, and control among Chinese hypertensive adults: the CHNS 1991–2009

Age, y 1991 1993 1997 2000 2004 2006 2009 ptrenda ptrendb

%(SE) %(SE) %(SE) %(SE) %(SE) %(SE) %(SE)
Awareness
Total 22.4 (1.3) 18.6 (1.1) 13.0 (0.8) 19.5 (0.9) 21.5 (0.9) 25.6 (0.9) 26.1 (0.9) <0.001 <0.001
Age, y
      18–39 15.0 (2.7) 7.1 (1.8) 4.4 (1.2) 8.5 (1.7) 8.6 (1.8) 12.1 (2.4) 11.6 (2.3) <0.001 <0.001
      40–59 30.5 (2.2) 30.0 (2.1) 20.3 (1.5) 29.9 (1.6) 34.1 (1.5) 37.7 (1.6) 38.7 (1.4) <0.001 <0.001
      ≥60 33.3 (2.2) 37.4 (2.2) 29.7 (1.7) 38.7 (1.7) 43.5 (1.6) 51.3 (1.6) 54.3 (1.4) 0.002 0.002
Sexes
    Men 17.6 (1.6) 16.7 (1.5) 11.0 (1.0) 16.4 (1.1) 18.1 (1.1) 24.3 (1.3) 24.3 (1.2) <0.001 <0.001
    Women 29.7 (2.0) 20.7 (1.7) 16.1 (1.3) 23.0 (1.4) 26.3 (1.4) 26.3 (1.3) 27.9 (1.2) <0.001 <0.001
Regions
    Urban 24.0 (2.0) 23.3 (1.9) 17.7 (1.5) 20.7 (1.5) 24.1 (1.5) 30.0 (1.6) 30.2 (1.5) 0.001 <0.001
    Rural 20.8 (1.6) 15.4 (1.4) 10.1 (0.9) 18.3 (1.1) 19.5 (1.1) 22.8 (1.1) 23.6 (1.0) <0.001 <0.001
Treatment
Total 12.0 (1.0) 10.1 (0.9) 9.6 (0.7) 13.6 (0.8) 16.6 (0.8) 19.0 (0.8) 22.8 (0.8) 0.027 <0.001
Age, y
      18–39 7.3 (1.9) 3.4 (1.2) 3.7 (1.1) 4.9 (1.3) 5.6 (1.5) 7.1 (1.9) 10.5 (2.2) 0.073 0.052
      40–59 17.1 (1.8) 15.3 (1.7) 14.1 (1.3) 21.0 (1.4) 26.9 (1.4) 28.8 (1.5) 32.3 (1.4) 0.025 <0.001
      ≥60 19.3 (1.8) 24.1 (1.9) 22.6 (1.5) 30.5 (1.6) 36.2 (1.5) 43.3 (1.5) 49.0 (1.4) 0.812 <0.001
Sexes
    Men 8.8 (1.2) 9.1 (1.2) 8.1 (0.9) 10.9 (1.0) 13.4 (1.0) 17.2 (1.1) 20.6 (1.1) 0.468 <0.001
    Women 17.0 (1.7) 11.2 (1.3) 12.1 (1.2) 16.6 (1.2) 20.9 (1.3) 20.6 (1.2) 25.4 (1.2) 0.014 <0.001
Regions
    Urban 14.6 (1.6) 14.6 (1.6) 14.1 (1.4) 15.4 (1.3) 19.5 (1.4) 22.2 (1.5) 28.0 (1.5) 0.318 <0.001
    Rural 10.1 (1.2) 7.2 (1.0) 7.1 (0.8) 12.0 (0.9) 14.4 (1.0) 16.8 (1.0) 19.8 (1.0) 0.038 <0.001
Control Among hypertensive patients
Total 3.0 (0.5) 2.6 (0.5) 1.7 (0.3) 3.3 (0.4) 4.6 (0.4) 4.5 (0.4) 6.1 (0.5) 0.775 <0.001
Age, y
      18–39 2.9 (1.3) 2.1 (1.0) 0.4 (0.4) 1.7 (0.8) 1.7 (0.8) 1.1 (0.8) 3.2 (1.3) 0.043 0.093
      40–59 3.3 (0.9) 3.0 (0.8) 3.1 (0.7) 4.8 (0.7) 7.4 (0.8) 7.9 (0.9) 8.3 (0.8) 0.819 <0.001
      ≥60 2.4 (0.7) 3.8 (0.9) 3.7 (0.7) 6.1 (0.8) 9.3 (0.9) 10.1 (0.9) 12.0 (0.9) 0.372 <0.001
Sexes
    Men 2.3 (0.6) 2.4 (0.6) 1.5 (0.4) 2.4 (0.5) 3.8 (0.6) 4.1 (0.6) 5.4 (0.6) 0.987 <0.001
    Women 4.0 (0.9) 3.1 (0.7) 2.1 (0.5) 4.6 (0.7) 6.0 (0.7) 4.5 (0.6) 7.0 (0.7) 0.653 <0.001
Regions
    Urban 3.2 (0.8) 3.4 (0.8) 2.3 (0.6) 4.4 (0.7) 5.4 (0.8) 6.1 (0.8) 9.5 (1.0) 0.753 <0.001
    Rural 2.7 (0.7) 2.3 (0.6) 1.3 (0.4) 2.6 (0.5) 3.8 (0.5) 3.5 (0.5) 4.4 (0.5) 0.542 <0.001
Among those treated
Total 29.7 (3.2) 42.6 (3.4) 17.4 (2.4) 29.7 (2.1) 32.8 (1.9) 21.4 (1.5) 33.1 (1.6) 0.211 0.008
Age, y
      18–39 40.0 (12.6) 62.5 (17.1) 12.5 (11.7) 35.7 (12.8) 36.4 (14.5) 16.7 (10.8) 37.5 (12.1) 0.349 0.247
      40–59 19.5 (4.4) 19.7 (4.6) 25.6 (4.8) 23.5 (3.2) 29.0 (2.9) 28.5 (2.8) 28.8 (2.6) 0.275 0.317
      ≥60 12.7 (3.3) 16.4 (3.3) 18.1 (3.2) 20.2 (2.5) 27.0 (2.4) 24.2 (2.1) 25.9 (1.8) 0.269 0.014
Sexes
    Men 35.4 (5.4) 28.6 (4.7) 12.6 (3.1) 23.3 (3.1) 27.9 (2.8) 23.6 (2.4) 30.9 (2.3) 0.267 0.295
    Women 26.0 (4.0) 47.6 (4.9) 19.9 (3.6) 37.7 (3.0) 35.2 (2.6) 12.1 (1.6) 39.8 (2.2) 0.504 0.006
Regions
    Urban 24.5 (4.1) 34.1 (4.4) 19.7 (3.5) 27.1 (3.0) 27.7 (2.6) 27.5 (2.4) 47.3 (2.4) 0.304 0.026
    Rural 34.4 (5.0) 65.8 (4.9) 12.5 (3.1) 28.7 (3.0) 34.8 (2.8) 17.9 (2.0) 26.6 (2.0) 0.450 0.109

Definitions of awareness, treatment, and control among Chinese hypertensive adults were presented in the Methods section.

Proportions were age-standardized to the China 2000 Census population

a

Time trends in estimated percentages from 1991 to 1997 were assessed by multiple logistical regression analysis with gender, age, region, and BMI adjustment.

b

Time trends in estimated percentages from 1997 to 2009 were assessed by multiple logistical regression analysis with gender, age, region, and BMI adjustment.

To our knowledge, although three regional studies have been published [68], we firstly reported the recent trends in prevalence, awareness, treatment and control of hypertension among the partially representative Chinese adults from 1991 to 2009, based on the CHNS. The upward trend in mean SBP and DBP values and prevalence of hypertension was observed among Chinese adults from 1991 to 2009, which might be due to decreases in physical activity [14], increases in sedentary behavior, high fat diet, salt intake [15] and obesity [16]. In contrast, the United States National Health and Nutrition Examination Survey (NHNES) conducted for a similar period (1988–2008) showed that the prevalence of hypertension increased from 1988 to 2000, with little change between 2000 and 2008[17]. Better public health education and preventive measures from the government and health professionals might explain the increases in the awareness, treatment and control rates between 1997 and 2009. Similarly, the NHNES in the United States also demonstrated an increase in awareness, treatment and control of hypertension between 1988 and 2008[18].

Two limitations are noted. First, BP measurement at a single visit usually overestimates hypertension prevalence and underestimates control rate. Second, risk factors such as diabetes, hyperlipidemia, smoking, and family history of hypertension and data on treatment medications and prevalence of essential versus non-essential hypertension were unavailable presently.

The overall prevalence of hypertension increased significantly in China between 1991 and 2009. The overall awareness, treatment, and control of hypertension (in hypertensive individuals) increased over time, but are still unacceptably low. Our results suggest an urgent need for a national hypertension education program to improve the prevention, detection, treatment, and control of hypertension in China, with the ultimate goal to lower hypertension-related morbidity and mortality.

Acknowledgments

Funding

This work was supported by the NIH (R01-HD30880, DK056350, R01-HD38700), National “Twelfth Five-Year” Plan for Science & Technology Support Program (2012BAI03B03), the Independent Innovation Foundation of Shandong University (2010GN046), the China Postdoctoral Science Foundation funded project (20100481252) and the Foundation for Outstanding Young Scientist in Shandong Province (BS2011YY026).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflict of interest statement

No conflicts of interest to declare.

Author Contribution

Bo Xi and Weihong Tang designed the study. Bo Xi and Yanjun Liang drafted the manuscript. Bo Xi, Yajun Liang and Yuehua Hu performed the data analysis. Weihong Tang and Kathleen H. Reilly made critical revisions.

References

  • 1.Ezzati M, Vander Hoorn S, Lawes CMM, Leach R, James WPT, Lopez AD, et al. Rethinking the “diseases of affluence” paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med. 2005;2:404–412. doi: 10.1371/journal.pmed.0020133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wang LD, editor. Nutrition and Health Status in Chinese People. Beijing, China: People’s Publishing House; 2005. [Google Scholar]
  • 3.Wu X, Duan X, Gu D, Hao J, Tao S, Fan D. Prevalence of hypertension and its trends in Chinese populations. Int J Cardiol. 1995;52:39–44. doi: 10.1016/0167-5273(95)02443-z. [DOI] [PubMed] [Google Scholar]
  • 4.Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008;118:2679–2686. doi: 10.1161/CIRCULATIONAHA.108.788166. [DOI] [PubMed] [Google Scholar]
  • 5.Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9:469–480. doi: 10.1016/S1474-4422(10)70066-1. [DOI] [PubMed] [Google Scholar]
  • 6.Meng XJ, Dong GH, Wang D, Liu MM, Lin Q, Tian S, et al. Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study. J Hypertens. 2011;29:1303–1310. doi: 10.1097/HJH.0b013e328347f79e. [DOI] [PubMed] [Google Scholar]
  • 7.Yang J, Lu F, Zhang C, Liu Z, Zhao Y, Gao F, et al. Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertens Res. 2010;33:331–337. doi: 10.1038/hr.2009.235. [DOI] [PubMed] [Google Scholar]
  • 8.Li H, Meng Q, Sun X, Salter A, Briggs NE, Hiller JE. Prevalence, awareness, treatment, and control of hypertension in rural China: results from Shandong Province. J Hypertens. 2010;28:432–438. doi: 10.1097/HJH.0b013e328334b39e. [DOI] [PubMed] [Google Scholar]
  • 9.Popkin BM, Du S, Zhai F, Zhang B. Cohort Profile: The China Health and Nutrition Survey--monitoring and understanding socio-economic and health change in China, 1989–2011. Int J Epidemiol. 2010;39:1435–1440. doi: 10.1093/ije/dyp322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572. doi: 10.1001/jama.289.19.2560. [DOI] [PubMed] [Google Scholar]
  • 11.Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003;290:199–206. doi: 10.1001/jama.290.2.199. [DOI] [PubMed] [Google Scholar]
  • 12.Li C, Ford ES, Mokdad AH, Cook S. Recent trends in waist circumference and waist-height ratio among US children and adolescents. Pediatrics. 2006;118:e1390–e1398. doi: 10.1542/peds.2006-1062. [DOI] [PubMed] [Google Scholar]
  • 13.Coats AJS, Shewan LG. Statement on Authorship and Publishing Ethics in the International Journal of Cardiology. Int J Cardiol. 2011;153:239–240. doi: 10.1016/j.ijcard.2011.10.119. [DOI] [PubMed] [Google Scholar]
  • 14.Ng SW, Norton EC, Popkin BM. Why have physical activity levels declined among Chinese adults? Findings from the 1991–2006 China Health and Nutrition Surveys. Soc Sci Med. 2009;68:1305–1314. doi: 10.1016/j.socscimed.2009.01.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zhai F, Wang H, Du S, He Y, Wang Z, Ge K, Popkin BM. Prospective study on nutrition transition in China. Nutr Rev. 2009;67:S56–S61. doi: 10.1111/j.1753-4887.2009.00160.x. [DOI] [PubMed] [Google Scholar]
  • 16.Xi B, Liang Y, He T, Reilly KH, Hu Y, Wang Q, et al. Secular trends in the prevalence of general and abdominal obesity among Chinese adults, 1993–2009. Obes Rev. 2012;13:287–296. doi: 10.1111/j.1467-789X.2011.00944.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303:2043–2050. doi: 10.1001/jama.2010.650. [DOI] [PubMed] [Google Scholar]
  • 18.Muntner P, Gu D, Wu X, Duan X, Wenqi G, Whelton PK, et al. Factors associated with hypertension awareness, treatment, and control in a representative sample of the Chinese population. Hypertension. 2004;43:578–585. doi: 10.1161/01.HYP.0000116302.08484.14. [DOI] [PubMed] [Google Scholar]

RESOURCES